FI106961B - Menetelmä terapeuttisesti käyttökelpoisten bis-indolyyli-1H-pyrroli-2,5-dionijohdannaisten valmistamiseksi - Google Patents

Menetelmä terapeuttisesti käyttökelpoisten bis-indolyyli-1H-pyrroli-2,5-dionijohdannaisten valmistamiseksi Download PDF

Info

Publication number
FI106961B
FI106961B FI942158A FI942158A FI106961B FI 106961 B FI106961 B FI 106961B FI 942158 A FI942158 A FI 942158A FI 942158 A FI942158 A FI 942158A FI 106961 B FI106961 B FI 106961B
Authority
FI
Finland
Prior art keywords
formula
tetrahydropyrido
indolyl
pyrrole
methyl
Prior art date
Application number
FI942158A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI942158A7 (fi
FI942158A0 (fi
Inventor
Christopher Huw Hill
Geoffrey Lawton
William Harris
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939309602A external-priority patent/GB9309602D0/en
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of FI942158A0 publication Critical patent/FI942158A0/fi
Publication of FI942158A7 publication Critical patent/FI942158A7/fi
Application granted granted Critical
Publication of FI106961B publication Critical patent/FI106961B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Virology (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Cephalosporin Compounds (AREA)
FI942158A 1993-05-10 1994-05-10 Menetelmä terapeuttisesti käyttökelpoisten bis-indolyyli-1H-pyrroli-2,5-dionijohdannaisten valmistamiseksi FI106961B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB939309602A GB9309602D0 (en) 1993-05-10 1993-05-10 Substituted pyrroles
GB9309602 1993-05-10
GB9403249A GB9403249D0 (en) 1993-05-10 1994-02-21 Substituted pyrroles
GB9403249 1994-02-21

Publications (3)

Publication Number Publication Date
FI942158A0 FI942158A0 (fi) 1994-05-10
FI942158A7 FI942158A7 (fi) 1994-11-11
FI106961B true FI106961B (fi) 2001-05-15

Family

ID=26302877

Family Applications (1)

Application Number Title Priority Date Filing Date
FI942158A FI106961B (fi) 1993-05-10 1994-05-10 Menetelmä terapeuttisesti käyttökelpoisten bis-indolyyli-1H-pyrroli-2,5-dionijohdannaisten valmistamiseksi

Country Status (25)

Country Link
EP (1) EP0624586B1 (de)
JP (1) JP2668818B2 (de)
CN (1) CN1048014C (de)
AT (1) ATE184007T1 (de)
AU (1) AU678435B2 (de)
BG (1) BG98761A (de)
BR (1) BR9401935A (de)
CA (1) CA2121567A1 (de)
CZ (1) CZ112894A3 (de)
DE (1) DE69420310T2 (de)
DK (1) DK0624586T3 (de)
ES (1) ES2137281T3 (de)
FI (1) FI106961B (de)
GR (1) GR3031901T3 (de)
HR (1) HRP940287B1 (de)
HU (1) HU215954B (de)
IL (1) IL109547A (de)
IS (1) IS1690B (de)
LT (1) LT3288B (de)
LV (1) LV11173B (de)
NO (1) NO301230B1 (de)
NZ (1) NZ260475A (de)
RU (1) RU2141960C1 (de)
SI (1) SI0624586T1 (de)
SK (1) SK53594A3 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG63570A1 (en) * 1993-12-07 1999-03-30 Lilly Co Eli Protein kinase c inhibitors
US5624949A (en) * 1993-12-07 1997-04-29 Eli Lilly And Company Protein kinase C inhibitors
US5843935A (en) * 1993-12-07 1998-12-01 Eli Lilly And Company Protein kinase C inhibitors
US5723456A (en) * 1993-12-07 1998-03-03 Eli Lilly & Company Therapeutic treatment for cardiovascular diseases
EP1449529B1 (de) * 1993-12-23 2010-01-27 Eli Lilly And Company Proteinkinase C Inhibitoren
EP0695755B1 (de) * 1994-08-04 1998-10-21 F. Hoffmann-La Roche AG Pyrrolocarbazol
CN1225634A (zh) * 1996-03-20 1999-08-11 伊莱利利公司 吲哚马来酰亚胺的合成
KR100499190B1 (ko) * 1996-03-29 2006-04-17 교와 핫꼬 고교 가부시끼가이샤 육모제
US5859261A (en) * 1997-03-20 1999-01-12 Eli Lilly And Company Synthesis of indolylmaleimides
BR0112965A (pt) 2000-07-27 2003-07-08 Hoffmann La Roche Derivados de 3-indolil-4-fenil-1h-pirrol-2,5-diona como inibidores de glocogênio sintase cinase-3beta
PL211461B1 (pl) * 2001-10-30 2012-05-31 Dana Farber Cancer Inst Inc Zastosowanie pochodnych staurosporyny do wytwarzania kompozycji farmaceutycznej do leczenia lub zapobiegania białaczkom i zespołom mielodysplastycznym, preparat farmaceutyczny do leczenia białaczek i zestaw farmaceutyczny
CA2393720C (en) 2002-07-12 2010-09-14 Eli Lilly And Company Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride
MXPA06001524A (es) 2003-08-08 2006-05-15 Novartis Ag Combinaciones que comprenden estaurosporinas.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3803620A1 (de) * 1988-02-06 1989-08-17 Goedecke Ag Indolocarbazol-derivate, verfahren zu deren herstellung und diese enthaltende arzneimittel
IL89167A (en) * 1988-02-10 1994-02-27 Hoffmann La Roche Substituted pyrroles, their manufacture and pharmaceutical compositions containing them
DE3833008A1 (de) * 1988-09-29 1990-04-05 Goedecke Ag Pyrrolocarbozol-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel
MC2096A1 (fr) * 1989-02-23 1991-02-15 Hoffmann La Roche Pyrroles substitues
CA2046801C (en) * 1990-08-07 2002-02-26 Peter D. Davis Substituted pyrroles

Also Published As

Publication number Publication date
LT3288B (en) 1995-06-26
IS1690B (is) 1998-04-20
EP0624586A1 (de) 1994-11-17
ES2137281T3 (es) 1999-12-16
HUT71492A (en) 1995-11-28
LV11173A (lv) 1996-04-20
IL109547A (en) 1998-07-15
DE69420310T2 (de) 2000-04-13
BR9401935A (pt) 1995-03-07
NO941682D0 (no) 1994-05-06
EP0624586B1 (de) 1999-09-01
HU215954B (hu) 1999-03-29
FI942158A7 (fi) 1994-11-11
CA2121567A1 (en) 1994-11-11
GR3031901T3 (en) 2000-02-29
SK53594A3 (en) 1995-02-08
NZ260475A (en) 1996-02-27
DE69420310D1 (de) 1999-10-07
BG98761A (en) 1995-03-31
JPH06329672A (ja) 1994-11-29
NO941682L (no) 1994-11-11
HRP940287B1 (en) 2000-02-29
IL109547A0 (en) 1994-08-26
HU9401298D0 (en) 1994-08-29
CZ112894A3 (en) 1994-12-15
IS4162A (is) 1994-11-11
ATE184007T1 (de) 1999-09-15
DK0624586T3 (da) 2000-03-27
LV11173B (en) 1996-06-20
NO301230B1 (no) 1997-09-29
RU2141960C1 (ru) 1999-11-27
JP2668818B2 (ja) 1997-10-27
LTIP1927A (en) 1994-11-25
FI942158A0 (fi) 1994-05-10
CN1048014C (zh) 2000-01-05
CN1103402A (zh) 1995-06-07
AU678435B2 (en) 1997-05-29
HRP940287A2 (en) 1996-12-31
AU6055594A (en) 1994-11-17
SI0624586T1 (en) 1999-12-31

Similar Documents

Publication Publication Date Title
KR102851932B1 (ko) Pad4 억제제로서의 치환된 티에노피롤
KR100916613B1 (ko) 단백질 키나제 ｃ 억제제로서의 인돌릴말레이미드 유도체
FI106961B (fi) Menetelmä terapeuttisesti käyttökelpoisten bis-indolyyli-1H-pyrroli-2,5-dionijohdannaisten valmistamiseksi
KR100756686B1 (ko) 이성질체 접합 피롤로카르바졸 및 이소인돌론
FI85482C (fi) Foerfarande foer framstaellning av nya terapeutiskt aktiva 9-/3-(4-guanidinofenyl) propylamino/oktahydro-10 oxo-6h-pyridazo/1,2-a//1,2/diazepin-1-karboxylsyraderivat.
JP5199079B2 (ja) アンドロゲン受容体モジュレーター化合物および方法
FI88295B (fi) Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara 5-karbonylamino-4-hydroxi-n-hexanamidderivat
JPH11503419A (ja) ファルネシル−タンパク質トランスフェラーゼ阻害剤
KR20080002809A (ko) 신규 이소인돌 유도체, 그를 함유하는 조성물, 그의 제조방법, 및 특히 샤페론 단백질 ｈｓｐ90 활성의억제제로서의 그의 제약 용도
HUT71617A (en) Peptide-boronic acid derivatives, process for producing them and pharmaceutical application thereof
CA2159482A1 (en) Fibrinogen receptor antagonists
US5721230A (en) Substituted pyrroles
Boisbrun et al. A Convenient Synthesis of Indole‐Substituted 2‐Pyrrolidones and Their Cyclized Derivatives
HU198937B (en) Process for producing indolopyrazino benzodiazepine derivatives and pharmaceutical compositions comprising same
JP2000507586A (ja) ファルネシル―タンパク質転移酵素の阻害剤
KR100331515B1 (ko) 치환된피롤
EP0145304B1 (de) Tetrahydro-beta-carbolinderivate und Verfahren zu ihrer Herstellung
AU7395098A (en) 5-((Heteroaryl)Alkyl)-3-Oxo-Pyrido(1,2-a) Benzimidazole-4- carboxamide derivatives useful in treating central nervous system disorders
EP1268429A1 (de) Bicyclische verbindungen als vitronectinrezeptorantagonisten, verfahren zur ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
AU2003255575B2 (en) Novel imidazole compounds, method for preparing same and use thereof as medicines

Legal Events

Date Code Title Description
MA Patent expired